The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Astellas Pharma Europe B.V.EU/1/23/1771/001-003

Main Information

Trade NameVeoza
Active SubstancesFezolinetant
Dosage FormFilm-coated tablet
Licence HolderAstellas Pharma Europe B.V.
Licence NumberEU/1/23/1771/001-003

Group Information

ATC CodeG02CX06 fezolinetant


License statusAuthorised
Licence Issued07/12/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply Status
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back